Back

Heart failure is the cancer for the heart: the prognostic importance of the new HLM classification

23 May 2022 (14:55 - 15:40)
Organised by:
Congress Presentation Part of: Acute heart failure: treatment and prognosis Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Andrea D'Amato

Sapienza University of Rome, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
Role of urinary potassium to creatinine ratio for tailoring the type of diuretic regimen in patients with acute heart failure and diuretic resistance
Doctor F. Croset (Madrid, ES)
Abstract Slides
Presentation thumbnail
Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish Heart Failure Registry
Doctor P. Becher (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Impact of obstructive sleep apnea in patients undergoing left ventricular assist device implantation
Doctor N. Patel (Hartford, US)
Abstract Slides
Presentation thumbnail
Clinical, laboratory associates and prognostic significance of hypocapnia in acute heart failure. 
Mr M. Garus (Wroclaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Acute heart failure: treatment and prognosis

The Event

Event poster

Heart Failure 2022

23 May 2022 14:55 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of HFA-PEFF and H2FPEF scores in patients with advanced cancer: a prospective observational study
thumbnail
Congress Presentation
The chronic heart failure evolutions: different fates and routes
thumbnail
Congress Presentation
Cancer risks in heart failure patients: Insights from ischemic and non-ischemic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources